IP Library Granted Patent US 9,169,467
Granted Patent B2
US 9,169,467 · App. 13/891,963 · Granted Oct 27, 2015

Ketol-acid reductoisomerase enzymes and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,169,467
App. No.
13/891,963
Granted
Oct 27, 2015
Kind
B2
Abstract

Provided herein are polypeptides having ketol-aid reductoisomerase activity as well as microbial host cells comprising such polypeptides. Polypeptides provided herein may be used in biosynthetic pathways, including, but not limited to, isobutanol biosynthetic pathways.

Claims (24)

1. A polypeptide having ketol-acid reductoisomerase activity, wherein the polypeptide comprises

a. the amino acid sequence of SEQ ID NO: 41;

b. at least 99% identity to SEQ ID NO: 41;

c. at least 99% identity to SEQ ID NO: 41 and at least one of the following substitutions: M301I, Y239H, Y113F, S322A, A71K, N114G, A329R, A69T, N114S, G72W, A295V, E264K, R280D, A329E, S157T, M238I, Q272T, K335M, R280H, and a combination thereof; or

d. an active fragment of any one of (a) to (c).

2. The polypeptide of claim 1 , further comprising a substitution at at least one of position L33, P47, F50, F61, I80, and V156.

3. The polypeptide of claim 1 further comprising at least one of the following substitutions: I13L, P47Y, F50A, V53A, S86A, A268E, V76I, L88V, and a combination thereof.

4. A recombinant microbial host cell comprising the polypeptide of claim 1 .

5. The recombinant microbial host cell of claim 4 wherein said host cell further comprises reduced or eliminated acetolactate reductase activity.

6. The recombinant microbial host cell of claim 5 wherein said host cell further comprises at least one deletion, mutation, and/or substitution in fra2.

7. The recombinant microbial host cell of claim 4 further comprising the substrate to product conversions:

a. pyruvate to acetolactate

b. 2,3-dihydroxyisovalerate to α-ketoisovalerate

c. α-ketoisovalerate to isobutyraldehyde; and

d. isobutyraldehyde to isobutanol.

8. The recombinant microbial host cell of claim 4 wherein said host cell is a yeast host cell.

9. The recombinant microbial host cell of claim 8 wherein said host cell is Saccharomyces cerevisiae.

10. A method for converting acetolactate to dihydroxyisovalerate comprising:

a. providing a microbial host cell comprising a polypeptide of claim 1 ;

b. contacting the polypeptide with acetolactate wherein dihydroxyisovalerate is produced.

11. A method of producing a product selected from the group consisting of isobutanol, pantothenate, valine, leucine, isoleucine, 3, 3-dimethylmalate, and 2-methyl- 1-butanol or combinations thereof comprising:

a. providing the recombinant host cell of claim 4 wherein the recombinant host cell comprises a product biosynthetic pathway; and

b. contacting the microbial host cell with a carbon substrate under conditions whereby the product is produced.

12. The method of claim 11 wherein at least a portion of the contacting occurs under anaerobic conditions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →